These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1868760)
1. [Appropriate dosage for maintaining effective serum level at night after taking one dose of magnesium valproate with separate measurements of serum Mg++ concentration]. Yan CS Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):18-20, 61. PubMed ID: 1868760 [TBL] [Abstract][Full Text] [Related]
2. An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks. Samaei A; Nobahar M; Vafaei AA Pak J Pharm Sci; 2009 Apr; 22(2):180-3. PubMed ID: 19339229 [TBL] [Abstract][Full Text] [Related]
3. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate]. Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769 [TBL] [Abstract][Full Text] [Related]
4. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. Fudio S; Carcas A; Piñana E; Ortega R J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111 [TBL] [Abstract][Full Text] [Related]
5. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage. Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399 [TBL] [Abstract][Full Text] [Related]
6. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study. Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499 [TBL] [Abstract][Full Text] [Related]
7. Plasma sodium valproate levels and clinical response in epilepsy. Anthony M; Hinterberger H; Lance JW Clin Exp Neurol; 1977; 14():208-15. PubMed ID: 358186 [TBL] [Abstract][Full Text] [Related]
8. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study. Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050 [TBL] [Abstract][Full Text] [Related]
9. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy. Geda G; Caksen H; Içağasioğlu D Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250 [TBL] [Abstract][Full Text] [Related]
11. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up. McCabe PH; Michel NC; McNew CD; Lehman EB Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766 [TBL] [Abstract][Full Text] [Related]
12. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit. Boggs JG; Preis K Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337 [TBL] [Abstract][Full Text] [Related]
13. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician. Dutta S; Reed RC J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630 [TBL] [Abstract][Full Text] [Related]
15. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid. Arslan M; Vurucu S; Balamtekin N; Unay B; Akin R; Kurt I; Ozcan O Brain Dev; 2009 Jun; 31(6):405-10. PubMed ID: 18814980 [TBL] [Abstract][Full Text] [Related]
16. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants. Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674 [TBL] [Abstract][Full Text] [Related]
17. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156 [TBL] [Abstract][Full Text] [Related]
18. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels. Klotz U; Schweizer C Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028 [TBL] [Abstract][Full Text] [Related]
19. Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER? Reed RC; Dutta S Ther Drug Monit; 2006 Jun; 28(3):413-8. PubMed ID: 16778728 [TBL] [Abstract][Full Text] [Related]
20. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy. Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]